Grace Therapeutics logo

Grace Therapeutics

GRCE | NASDAQ
Chart Builder DCF Calculator
$1.75
-$0.06 (-3.31%)
At close: Nov 16, 2026, 4:00 PM ET
$1.75
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-3.31%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
34.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #676/1021 (Top 66%)

Key Statistics

Market Data

Market Cap $35.2M
1D Range
1.73 1.77
52W Range
1.73 5.13

Valuation (TTM)

PE -1.37
PB 0.63
EV/EBITDA -0.57

Valuation (NTM)

Forward PE N/A
Forward PEG 0.08
Price Target $4.00
Loading financial charts...

Profile

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The comp...

Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Feb 7, 2012
Fiscal Year April - March

Latest News

No news articles available yet.

Earnings

Next Earnings
Feb 15, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$4.00
Upside
+128.57%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.